Clinical Trial

Antegrade Autologous Blood Reinfusion After CPB

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective observational study aims to evaluate the effect of antegrade pump blood reinfusion using the crystalloid "chase" technique on postoperative transfusion requirements in adult patients undergoing cardiac surgery with cardiopulmonary bypass. At the end of cardiopulmonary bypass, blood remaining within the cardiopulmonary bypass circuit is reinfused antegradely through the arterial line using a crystalloid chase, without collection or storage. Blood remaining within the bypass circuit after surgery represents a valuable source of autologous blood, and its reinfusion may contribute to perioperative blood conservation strategies. Patients receiving antegrade pump blood reinfusion via the chase technique will be compared with those managed without reinfusion, without any intervention by the investigators. The primary outcome is postoperative blood transfusion requirement.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-12; most recent amendment 2026-02-23.
Status change: Not Yet Recruiting → Recruiting 2026-02-23
Trial Details
NCT Number NCT07420582
Lead Sponsor Kocaeli City Hospital
Conditions Coronary Artery Disease
Enrollment 130 participants
Start Date 2026-02-23
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-24